Biomerica (BMRA) Debt Ratio (2011 - 2012)
Biomerica (BMRA) reported Debt Ratio of 0.01 for Q2 2012, up 8.08% on a YoY basis from 0.01 in Q2 2011, and up 233.59% sequentially from 0.0 in Q4 2011.
Biomerica (BMRA) Debt Ratio (2011 - 2012) Analysis & Trends
Biomerica (BMRA) has 2 years of Debt Ratio data on file, last reported at 0.01 in Q2 2012.
- For the quarter ending Q2 2012, Debt Ratio rose 8.08% year-over-year to 0.01; the trailing twelve-month figure through May 2012 stood at 0.01 (up 8.08% YoY), and the FY2012 full-year result was 0.01, up 8.08% from the prior year.
- Debt Ratio improved to 0.01 in Q2 2012, from 0.0 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.01 in Q2 2012 to a low of 0.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.04 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.30 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.27 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 0.30 |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 0.01 |
| Nov 30, 2011 | 0.00 |
| Aug 31, 2011 | 0.00 |
| May 31, 2011 | 0.01 |